Discordance in Oncotype DX Breast Recurrence Score® Results for Bilateral Breast Cancer.

Joshua A BloomYurie SekigamiRebekah YoungLisa MaceraChristy A RussellYu CaoRachel J BuchsbaumStephen P NaberAbhishek Chatterjee

Published in: Annals of surgical oncology (2021)

This study shows that a clinically relevant rate of discordance in Oncotype DX results in patients with BBC may impact medical decision-making regarding chemotherapy.

Keyphrases

decision making
healthcare
locally advanced
squamous cell carcinoma
case report
radiation therapy